Baylor College of Medicine: Findings Support Repurposing Rheumatoid Arthritis Drug Auranofin For Diabetes
October 15, 2022
October 15, 2022
HOUSTON, Texas, Oct. 15 (TNSjou) -- The Baylor College of Medicine issued the following news on Oct. 14, 2022:
Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was conducted in mice, appeared today in the journal Cell Metabolism.
Although scientists have identified definitive associations between inflamma . . .
Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was conducted in mice, appeared today in the journal Cell Metabolism.
Although scientists have identified definitive associations between inflamma . . .